1-(Phenylsulfonyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-c]pyridine, 95.0%, 10g

5,6-Dibromo-benzo[1,2,5]thiadiazole, 95.0%, 1g

Cyclopentadecane, 98%, 250mg

2,3-Dichloro-6-nitroquinoxaline, 95.0%, 1g

(R)-3-((tert-Butoxycarbonyl)amino)-4-(2,4-difluorophenyl)butanoic acid, 95%, 1g

Undecane [Standard Material for GC]>99.5%(GC)5mL

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(2-((tert-butoxycarbonyl)amino)ethoxy)phenyl)propanoic acid, 97%, 100g

3-(Piperidine-1-carbonyl)phenylboronic acid, 95.0%, 1g

5-Chloro-2-methylpyrimidine-4-carboxylic acid, 95.0%, 1g

1-Bromo-4-hexyloxybenzene>98.0%(GC)25g

Polyvinylpyrrolidone K 30, 500 g

2-Chloro-1-ethynyl-4-methylbenzene, 98%, 250mg

1,3-Diamino-2-propanol-N,N,N',N'-tetraacetic Acid>98.0%(T)25g